Biomedical Engineering Reference
In-Depth Information
Since the conversionofAmust be between 0 (no conversion) and1 (100%conversion) inorder
for it to be physically possible, we discard the value that is greater than unit and obtain
f A ¼ 20 3
20 3
p
p
1
1199 ¼ 0:97194
(E5-4.14)
Next, we check if indeed this conversion gives the maximum gross profit. We can either
plot out the variation of GP$ vs f A to see if we indeed having a maximum GP$ at this
f A value or checking the second derivative of GP$,
d 2 GP$
d f A ¼
2 $ A F B
f A
2 $ V F B
kC A 0 1 f A 3
(E5-4.15)
Plug in the values we know up until this step, we obtain
d 2 GP$
d f A ¼
2 2ð
$
=
mol
Þ100ð
mol
=
h
Þ
0:97194 3
2 0:03½
$
lh
Þ 100ð
mol
=
h
Þ
3
0:15ðmin 1
Þ60ð
min
=
h
Þ2ð
mol
=
l
Þð1 0:97194Þ
Þ< 0
A negative second-order derivative means that the value of GP$ is lower for either higher
or lower f A . Thus, we indeed have obtained a maximum value of the gross profit at the
conversion of f A ¼
¼15527ð
$
=
h
0.97194. This confirms that the optimum conversion is f A ¼
0.97194.
The reactor size can be computed from Eqn (E5-4.4)
F B
100
0:15 60 2 ð1 0:97194Þ
V ¼
kC A 0 1 f A ¼
¼ 197:99 l
l
3. The cash flow based on the optimum conversion:
$ B F B
F A 0
F B
f A F A 0
F B
GP$
F A 0 ¼
kC A 0 1 f A F A 0
$ A
$ V
$ V f A
¼
$ B f A
$ A
kC A 0 1 f A
0:03 0:97194
0:15 60 2 ð1 0:97194Þ
¼ 5 0:97194 2
$
=
mol
A
¼
$ 2:802=
mol
A
4. At breaking even point, the net profit (or in this case the gross profit) is zero. Therefore,
at the break-even point, operating cost and the value of product are equal.
The value of product is,
$ B F B ¼ 5 100 $
=
h
¼ 500 $
=
h
which is also the operating cost at break-even.
Search WWH ::




Custom Search